Thorpe Gary H
1 Gary Thorpe Associates Ltd, Birmingham, England.
J Diabetes Sci Technol. 2019 May;13(3):553-558. doi: 10.1177/1932296818799365. Epub 2018 Sep 15.
The article by Macleod and coauthors outlines an accuracy study of two blood glucose monitoring systems (BGMSs) against glucose-oxidase- and hexokinase-based assays showing how the reference/comparison method and inappropriate sample comparisons can affect accuracy conclusions. The dangers of independent institutions producing inappropriate conclusions when the methodology used for product regulatory or registration accuracy requirements is not according to best practice are stressed. The authors highlight several important aspects of a multistep accuracy evaluation protocol. However, it is essential that anyone undertaking or reporting BGMS accuracy studies should have a clear understanding of each and every protocol point, best practice, and how each can influence accuracy conclusions. Claims against regulatory accuracy criteria should be made only if the detailed specified protocol design and analysis is followed.
麦克劳德及其合著者的文章概述了对两种血糖监测系统(BGMS)与基于葡萄糖氧化酶和己糖激酶的检测方法进行的准确性研究,展示了参考/比较方法以及不恰当的样本比较如何影响准确性结论。文中强调了在产品监管或注册准确性要求所采用的方法不符合最佳实践时,独立机构得出不当结论的风险。作者们突出了多步骤准确性评估方案的几个重要方面。然而,任何进行或报告BGMS准确性研究的人都必须清楚了解方案的每一个要点、最佳实践以及它们各自如何影响准确性结论。只有遵循详细规定的方案设计和分析,才能对监管准确性标准提出质疑。